|
Intelect’s management group has extensive medical device experience with neuromodulation and cardiovascular device companies.
Vincent Owens – Mr. Owens joined the Cleveland Clinic in February 2005 to lead the spin-out and Series A financing of Intelect Medical. Since inception, Intelect has raised $11 million in equity financing to fund its novel DBS therapies for recovery from stroke and TBI. Prior to joining Intelect, Mr. Owens was President and CEO of Texcel, an implantable CRM and Neuromodulation device company. Previously, Mr. Owens was founding CEO of Biomec Cardiovascular (BCI), a Minneapolis-based developer of proprietary implantable stimulation leads and delivery systems for the neuromodulation and CRM markets. He led BCI through acquisition by Enpath Medical (NASDAQ:NPTH) in 2003, after which he became President of Enpath - Lead Technologies. Mr. Owens was a founding employee of Biomec Inc. in Cleveland in 1998, and served in various capacities including VP Operations, President & CEO, and Board Member through Biomec’s acquisition by Greatbatch (NYSE:GB) in 2007. Earlier in his career, Mr. Owens held various operations, quality/regulatory, and engineering management roles at Ciba Corning (now Siemens), and in-vitro diagnostics company, and Circon ACMI (now Olympus), a medical endoscopy company. Mr. Owens serves on the boards of several privately held medical device companies and he is a member of several industry advisory boards, including Cornell University’s CCTEC, the technology transfer arm of the Weill Cornell Medical College, and Case Western’s Case-Coulter Translational Research Partnership (CCTRP). Mr. Owens earned a B.S. in Mechanical Engineering from Carnegie Mellon University and an MBA from Ashland University.
Steve LaPorte – Mr. LaPorte has had a long and distinguished career in the medical device industry including 27 years at Medtronic, including more than a decade as vice president and general manager of multiple divisions, including electrophysiology systems, drug delivery, and, most recently, Neuroventures. In these roles, he had extensive general operational and management experience as well as broad strategic planning and execution duties. LaPorte holds a BS in Mathematics and Computer Science, University of Wisconsin, Stevens Point, and an MBA from the University of Minnesota. Steve also holds a part-time role as Venture Partner for Onset Ventures, a technology venture capital firm based in Menlo Park, CA.
Scott Kokones – Mr. Kokones joined Intelect as one of its founding employees in 2005. He was promoted to VP, Research and Development in 2007 and is leading the development of Intelect's DBS system. Prior to joining Intelect, Mr. Kokones was the Research and Development Manager for Enpath Medical, responsible for the design and development of implantable stimulation leads in the fields of cardiac rhythm management and neuromodulation. Prior to Enpath, Mr. Kokones was employed at Medtronic as a Mechanical Design Engineer where he designed neurostimulation leads, adaptors and accessories for use on peripheral nerve stimulation, spinal cord stimulation and deep brain stimulation. He holds a Bachelors degree in Mechanical Engineering from the University of Michigan where he graduated with honors.
Robert L. Purcell III – Mr. Purcell joined Intelect in September of 2005 and serves as the company’s part-time CFO and Treasurer. He has 20 years of experience in accounting and operations management with a variety of medical device and manufacturing companies, including ElectroSonics Medical, Biomec Inc. and Allen Medical Systems. As VP Administration and Finance, and then VP of Operations for Biomec Inc., he helped lead the company through acquisition by Greatbatch (NYSE: GB) in 2007, Mr. Purcell currently serves as President, COO, Secretary and Treasurer of ElectroSonics Medical, a medical device company formed to commercialize certain technology assets of Biomec. Mr. Purcell served in the Ohio Army National Guard as a Material Control and Accounting Specialist and he received his B.A. in Accounting from The University of Akron and his M.B.A. from the Weatherhead School of Management at Case Western Reserve University. Mr. Purcell also serves on the board of several privately held medical device companies.
|
